ATORVASTATIN CALCIUM
- Product NDC
- 72189-239
- 11-digit product format
- 721890239
- Labeler code
- 72189
- Product ID
- 72189-239_2c283f9f-1dbb-4a4c-e063-6394a90a7953
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA204991
- Marketing category
- ANDA
- Marketing start
- 2021-09-20
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ATORVASTATIN CALCIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATORVASTATIN CALCIUM TRIHYDRATE | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 48A5M73Z4Q |
| Rxcui | 617312 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-239-90 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-239 | ATORVASTATIN CALCIUM TABLET, FILM COATED ATORVASTATIN CALCIUM TABLET [DIRECT RX] | 4 | Current NDC, Legacy NDC, 1 package rows | 20250121_c3b70f79-45a3-0869-e053-2a95a90a3cdb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-239-90 | 72189023990 | 90 TABLET in 1 BOTTLE (72189-239-90) | 90 tablet | 2021-09-20 | 0000-00-00 | No | No | Current |